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ReviewMechanisms of TGF- Signaling
from Cell Membrane to the Nucleus
have been observed in both TGF- family receptors and
the Smad proteins. The TGF- type II receptor is inacti-
vated by mutation in most human gastrointestinal can-
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1Lewis Thomas Laboratory
Department of Molecular Biology
Princeton University cers with microsatellite instability and Smad4 in nearly
half of all pancreatic carcinomas. Many other somaticWashington Road
Princeton, New Jersey 08544 and hereditary disorders are a result of mutations or
malfunctions in the TGF- pathway (reviewed in Mas-2 Cell Biology Program
Howard Hughes Medical Institute sague´ et al., 2000). Naturally occurring disease muta-
tions in Smads and TGF- family receptors have enor-Memorial Sloan-Kettering Cancer Center
New York, New York 10021 mously facilitated the analysis of the structure and
function of these proteins.
Over the last decade of intense investigation, many
key events in TGF- signaling have been documentedTGF- signaling controls a plethora of cellular re-
sponses and figures prominently in animal develop- at the molecular and cellular level. An earlier focus on
the cell biological characterization has now been com-ment. Recent cellular, biochemical, and structural stud-
ies have revealed significant insight into the mechanisms plemented by biochemical and structural investigation,
giving rise to an unprecedented level of clarity in severalof the activation of TGF- receptors through ligand
binding, the activation of Smad proteins through phos- aspects of the signal transduction process. In this re-
view, we focus on the molecular mechanisms of TGF-phorylation, the transcriptional regulation of target
gene expression, and the control of Smad protein signaling and present a comprehensive picture by syn-
thesizing the known cellular, biochemical, and structuralactivity and degradation. This article reviews these
latest advances and presents our current understand- features of the TGF- pathway common to all cell types
in organisms from fruit fly to human.ing on the mechanisms of TGF- signaling from cell
membrane to the nucleus.
TGF- Ligands and Receptors
Introduction The TGF- family of cytokines, characterized by six con-
Transforming Growth Factor  (TGF-) signaling con- served cysteine residues, are encoded by 42 open read-
trols a diverse set of cellular processes, including cell ing frames in human, 9 in fly, and 6 in worm (Lander et
proliferation, recognition, differentiation, apoptosis, and al., 2001). It contains two subfamilies, the TGF-/Activin/
specification of developmental fate, during embryogen- Nodal subfamily and the BMP (bone morphogenetic pro-
esis as well as in mature tissues, in species ranging tein)/GDF (growth and differentiation factor)/MIS (Muel-
from flies and worms to mammals (Patterson and Pad- lerian inhibiting substance) subfamily, as defined by
gett, 2000; ten Dijke et al., 2002; Massague´ et al., 2000). sequence similarity and the specific signaling pathways
A TGF- ligand initiates signaling by binding to and that they activate (Figure 2).
bringing together type I and type II receptor serine/thre- Although the diverse TGF- ligands elicit quite differ-
onine kinases on the cell surface. This allows receptor ent cellular responses, they all share a set of common
II to phosphorylate the receptor I kinase domain, which sequence and structural features. The active form of a
then propagates the signal through phosphorylation of TGF- cytokine is a dimer stabilized by hydrophobic
the Smad proteins (Figure 1). There are eight distinct interactions, which are further strengthened by an inter-
Smad proteins, constituting three functional classes: the subunit disulfide bridge in most cases (Figure 3A). Each
receptor-regulated Smad (R-Smad), the Co-mediator monomer comprises several extended  strands inter-
Smad (Co-Smad), and the inhibitory Smad (I-Smad). locked by three conserved disulfide bonds that form a
R-Smads (Smad1, 2, 3, 5, and 8) are directly phosphory- tight structure known as the “cysteine knot” (Sun and
lated and activated by the type I receptor kinases and Davies, 1995). The dimeric arrangement of the ligands
undergo homotrimerization and formation of hetero- suggests the formation of a complex with two type I and
meric complexes with the Co-Smad, Smad4 (Figure 1). two type II receptors. Ligand access to the receptors is
The activated Smad complexes are translocated into the regulated by a large family of proteins collectively known
nucleus and, in conjunction with other nuclear cofactors, as ligand traps (Figure 2). The crystal structure of the
regulate the transcription of target genes. The I-Smad, Noggin-BMP7 complex reveals that the ligand trap Nog-
Smad6 and Smad7, negatively regulate TGF- signaling gin inhibits BMP7 by blocking the surfaces that are re-
by competing with R-Smads for receptor or Co-Smad quired to interact with the type I and type II BMP recep-
interaction and by targeting the receptors for degrada- tors (Groppe et al., 2002) (Figure 3B).
tion (Figure 1). The receptor serine/threonine kinase family in the hu-
Because TGF- signaling generally has a negative man genome comprises 12 members—7 type I and 5
effect on cell growth, inactivation of this pathway con- type II receptors—all dedicated to TGF- signaling
tributes to tumorigenesis. Tumor-derived mutations (Manning et al., 2002) (Figure 2). Both types of the recep-
tor serine/threonine kinases consist of about 500 amino
acids, organized sequentially into an N-terminal extra-*Correspondence: yshi@molbio.princeton.edu (Y.S.), j-massague@
ski.mskcc.org (J.M.) cellular ligand binding domain, a transmembrane region,
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Figure 1. Schematic Diagram of TGF- Sig-
naling from Cell Membrane to the Nucleus
The arrows indicate signal flow and are color
coded: orange for ligand and receptor activa-
tion, gray for Smad and receptor inactivation,
green for Smad activation and formation of a
transcriptional complex, and blue for Smad
nucleocytoplasmic shuttling. Phosphate
groups and ubiquitin are represented by
green and red circles, respectively.
and a C-terminal serine/threonine kinase domain. The the hereditary disorder primary pulmonary hypertension
(De Caestecker and Meyrick, 2001). These mutants stilloverall structures of the extracellular ligand binding do-
main of the type I BMP receptor (Kirsch et al., 2000) as appear normal in their ability to activate Smads via BMP
type I receptors (Nishihara et al., 2002), raising the possi-well as the type II receptors for Activin (Greenwald et
al., 1999) and TGF- (Boesen et al., 2002) exhibit a similar bility that the BMPR-II tail has a critical, Smad-indepen-
dent signaling function.three-finger toxin fold, with each finger formed by a pair
of anti-parallel  strands (Figure 4A).
The type I, but not type II, receptors contain a charac-
Mechanism of Ligand Binding to the Receptorsteristic SGSGSG sequence, termed the GS domain, im-
Two distinct modes of the ligand-receptor interactionmediately N-terminal to the kinase domain. The activa-
exist, one exemplified by members of the BMP subfamilytion of the type I receptor involves the phosphorylation
and the other represented by TGF-s and Activins. BMPof its GS domain by the type II receptor; hence an active
ligands such as BMP2 and -4 exhibit a high affinity forreceptor signaling complex comprises both types of
the extracellular ligand binding domains of the type Ireceptors bound to the ligand. Several receptor variants
BMP receptors and a low affinity for the type II receptors.have N-terminal or C-terminal extensions, most of them
The preassembled type I receptor-ligand complex haswith as yet unknown function (Massague´, 1998). Trun-
a higher binding affinity for the type II receptor. Thecating mutations of a long C-terminal extension of the
structure of the homodimeric BMP2 in complex withhuman BMP type II receptor (BMPR-II) appear to cause
two ectodomains of the BMP type I receptor (BMPR-
IA) reveals that the receptor binds to the “wrist” epitope
of the BMP2 dimer and makes extensive contacts to
both BMP2 monomers (Kirsch et al., 2000) (Figure 4B).
These interactions are predominantly hydrophobic, with
Phe85 of BMPR-IA playing a key role. The aromatic side
chain of Phe85, with knob-into-hole packing, points into
a hydrophobic pocket formed at the interface of the two
BMP2 monomers. Phe85 is preserved or replaced by a
similar residue in all type I receptors except ALK1; all
residues that form the hydrophobic pocket in the dimeric
BMP2 are also highly conserved in all other TGF- li-
gands. This suggests that the hydrophobic knob-and-
pocket binding is essential for the interactions between
TGF- ligands and the type I receptors (Kirsch et al.,
2000).
In contrast to the BMPs, TGF- and Activin display a
Figure 2. A Schematic Relationship Describing TGF- Ligands, Li- high affinity for the type II receptors and do not interact
gand Binding Traps, Accessory Receptors, and the Type I and II
with the isolated type I receptors (Massague´, 1998). InReceptors in Vertebrates
this case, the ligand binds tightly to the ectodomain of
The downstream R-Smads 1, 2, 3, 5, and 8 are grouped based on
the type II receptor first; this binding allows the subse-their signaling specificity. Commonly used alternative names are:
quent incorporation of the type I receptor, forming aALK2/ActR-I, ALK3/BMPR-IA, ALK4/ActR-IB, ALK5/TR-I, and ALK6/
BMPR-IB. large ligand-receptor complex involving a ligand dimer
Review
687
Figure 3. TGF- Ligand and a Ligand Binding Trap
(A) Structure of a representative TGF- ligand, TGF-3 (Mittl et al.,
1996). The two monomers are colored blue and green, respectively.
Cysteine side chains and disulfide bonds are represented by red
lines. Note the dimeric ligand is linked by a disulfide bond.
(B) Structure of a Noggin dimer (colored purple) in complex with a
BMP-7 homodimer. The N-terminal fragments of Noggin interact
with the same surface areas of BMP-7 as required for binding to
the type I and II receptors. A critical residue Pro35 of Noggin is
shown in yellow. This residue occupies the same hydrophobic
Figure 4. Assembly of the Ligand-Receptor Complexespocket of BMP-7 as required for binding to Phe85 of the type I BMP
receptor. Figures 3, 4, 5, 6, and 8 were prepared using MOLSCRIPT (A) Structure of the extracellular ligand binding domain of the type
(Kraulis, 1991). II TGF- receptor (Boesen et al., 2002; Marlow et al., 2003). The
structure resembles the so-called three-finger toxin fold (Greenwald
et al., 1999).
and four receptor molecules. Structural analysis of the (B) Structure of the extracellular ligand binding domain of the type
IA BMP receptor bound to BMP2 (Kirsch et al., 2000). The highlyectodomain of the human TGF- type II receptor (TRII)
conserved residue in type I receptors (Phe85 in BMPR-IA) is shownin complex with TGF-3 reveals that the binding occurs
in yellow.at the far ends (so-called “fingertips”) of the elongated
(C) Structure of the extracellular ligand binding domain of the type
ligand dimer (Hart et al., 2002) (Figure 4C). Each receptor II TGF- receptor bound to TGF-3 (Hart et al., 2002). The disordered
only binds to one monomer of the dimeric TGF-3. This “wrist” regions of the BMP2 dimer are indicated by red ovals
interaction creates two symmetrically positioned con- whereas the predicted TRI binding sites are shown by red circles.
The orientation of TGF-3 is the same as BMP2 in (B).cave surface patches, which were postulated to be the
(D) Structure of the extracellular ligand binding domain of the typebinding site for the ectodomain of the type I receptor
II Activin receptor bound to BMP7 (Greenwald et al., 2003). Com-(Figure 4C).
pared to TRII-TGF3, ActRII uses a different ligand binding epitope
Although the interactions between the type I receptors to contact a different surface on BMP7. The orientation of BMP-7
and their associated ligands appear to be conserved is related to that of BMP2 (B) by a clockwise 50 rotation along an
for all TGF- family members, significant variation exists axis perpendicular to the paper.
(E) A structural model of the complete extracellular TGF- receptorfor the binding between the different subfamilies of the
complex. The structure of the BMPR-IA was used to model thetype II receptors and their ligands (Gray et al., 2000;
extracellular ligand binding domain of the type I receptor of TGF-Hart et al., 2002). The Activin type II receptor has a
receptor. The modeled structure is viewed along the plasma mem-
broad specificity and can bind to both Activin and BMP brane. The C termini of the receptors are represented by dashed
ligands. Compared to TRII, the ectodomain of the Ac- lines going into the plasma membrane.
tivin type II receptor (ActRII) contains a quite different
ligand binding epitope, as documented in its cocrystal
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structure with either BMP7 (Greenwald et al., 2003) (Fig- with its downstream target Smad2, the phosphorylated
TRI protein binds efficiently to Smad2 in vitro and ex-ure 4D) or with Activin A (Thompson et al., 2003). Se-
quence analysis suggests that MIS and AMHR-II may hibits a dramatically enhanced phosphorylation speci-
ficity for the C-terminal serine residues of Smad2 (Huseuse a third unique binding interface (Greenwald et al.,
2003), further highlighting the complexity in ligand bind- et al., 2001) (Figure 5). In addition, the tetra-phosphory-
lated TRI can no longer be recognized by the inhibitorying to the type II receptors. These observations identify
different modes of receptor complex assembly and sup- protein FKBP12. Thus, phosphorylation activates TRI
by switching the GS region from a preferred bindingport the idea that the type II receptors play a more
important role in the determination of specificity for the site for an inhibitor into a binding surface for R-Smad
substrates.assembly of the receptor signaling complex.
Two contrasting models have been proposed to ex-
plain the two-step assembly of a functional signaling Regulation of Receptor Activation
complex for TGF-s and Activins. In the allosteric model, The steps leading to receptor activation are tightly regu-
the binding of ligand to the type II receptor is required lated. The access of TGF- ligands to their receptors is
to induce a conformational change in the ligand, which controlled by two classes of molecules with opposing
leads to exposure of the binding epitope for the type I function (Figures 1 and 2). One class comprises a diverse
receptor. Supporting this model, the TRII bound TGF- group of soluble proteins that act as ligand binding
3 does undergo a large conformational change com- traps, sequestering the ligand and barring its access to
pared to its uncomplexed form (Hart et al., 2002) (Figures membrane receptors. They include the proregion of
3A and 4C). In the cooperative model, the ectodomain TGF- precursor, which after cleavage in the secretory
of the type I receptor interacts with an extended surface pathway remains noncovalently bound to the bioactive
that relies on the formation of the type II receptor-ligand domain as a “latency-associated polypeptide” (LAP).
complex. The cooperative model was thought to apply They also include the small proteoglycan decorin and
to the assembly of TGF- ligand-receptor complex the circulating protein 2-macroglobulin, which bind to
based on modeling studies (Hart et al., 2002). However, free TGF-; follistatin, which binds to Activins and
the structure of ActRII-BMP7, together with that of the BMPs; and three distinct protein families—Noggin,
BMPRIA-BMP2 complex (Kirsch et al., 2000), allows the Chordin/SOG, and DAN/Cerberus—whose members
molecular construction of a model for the BMP7-ActRII- also bind to BMPs.
BMPRIA complex (Greenwald et al., 2003). In this model, Our knowledge of the biological role of these proteins
the ectodomains of the type I and type II receptors do has been extensively reviewed (Balemans and Van Hul,
not directly contact each other; yet these two receptors 2002; Harland, 2001; Massague´ and Chen, 2000), but
bind cooperatively to the BMP7 ligand. Thus this co- until recently our understanding of how these factors
operativity is likely derived from an allosteric effect block TGF- ligands was lacking. The resolution of the
(Greenwald et al., 2003). crystal structure of the Noggin-BMP7 complex has re-
vealed for the first time how one of these factors binds
to its target and prevents it from contacting membraneMechanism of Receptor Activation
Binding to the extracellular domains of both types of receptors (Groppe et al., 2002). Noggin is a critical regu-
lator of BMP activity during vertebrate dorsal-ventralthe receptors by the dimeric ligand induces a close
proximity and a productive conformation for the intracel- patterning, neuronal induction and differentiation, and
skeletogenesis and joint formation (Brunet et al., 1998;lular kinase domains of the receptors, facilitating the
phosphorylation and subsequent activation of the type Gong et al., 1999; Lim et al., 2000). Noggin functions as
an antagonist of several BMPs, including BMP7. TheI receptor (Figure 4E). The type II receptor kinases are
thought to be constitutively active, although the regula- structure of the Noggin-BMP7 complex reveals that
Noggin inhibits BMP7 by blocking the surfaces that aretion of this process remains unclear. The type II receptor
kinase phosphorylates multiple serine and threonine required to interact with the type I and type II BMP
receptors (Groppe et al., 2002) (Figure 3B). The N-ter-residues in the TTSGSGSG sequence of the cytoplasmic
GS region of the type I receptor, leading to its activation minal segment of each Noggin monomer adopts an
extended conformation and wraps around a BMP7(Massague´, 1998) (Figure 5). Because of its critical role
in receptor activation, the GS region serves as an impor- monomer, directly occupying the receptor contact sites.
A proline residue in this segment, Pro35, fills the BMP7tant regulatory domain for TGF- signaling. For exam-
ple, the immunophilin FKBP12 inhibits TGF- signaling hydrophobic pocket that normally accommodates
Phe85 in the type I receptor. Interestingly, the core struc-by binding to the unphosphorylated GS regions of the
type I receptors (Huse et al., 1999). This interaction also ture of the Noggin monomer contains a cysteine knot.
This, and the overall structural configuration suggestlocks the kinase catalytic center of the type I receptors
in an unproductive conformation (Figure 5). that ligand and antagonist may have evolved from a
common ancestor.Significant details on the mechanism of receptor acti-
vation were revealed by a recent study in which a TRI The other class of molecules that control ligand ac-
cess to receptors includes membrane-anchored pro-protein homogeneously tetra-phosphorylated in the GS
region was generated using an in vitro protein ligation teins that act as accessory receptors, or coreceptors,
promoting ligand binding to the signaling receptors.strategy (Huse et al., 2001). This represents the first
successful example of chemically creating a phosphory- Recent work has revealed that the coreceptors for the
TGF- family play a broader role than previouslylated molecule to study TGF- signaling. In contrast to
the inability of the unphosphorylated TRI to interact thought. The membrane-anchored proteoglycan beta-
Review
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Figure 5. Activation of the Type I Receptor Kinase and Recognition of R-Smad
In the basal state, type I receptor remains unphosphorylated (Huse et al., 2001). This conformation can be recognized either by FKBP12 (Huse
et al., 1999) for sequestration in an inactive state (leftward arrow) or by TRII for phosphorylation in the GS domain (rightward arrow). After
phosphorylation, TRI uses its GS domain and L45 loop to interact with the basic pocket and L3 loop of an R-Smad, resulting in its
phosphorylation in the C-terminal SXS motif. The pThr/pSer-X-pSer motif on the R-Smad and the type I receptor is shown as green spheres.
glycan, also known as the TGF- type III receptor, has tive feedback loop that helps ensure a proper level of
BMP signaling.long been known to mediate TGF- binding to the type
II receptor, a role that is particularly critical for TGF-2 Receptor activation is also regulated by intracellular
proteins. Binding of FKBP12 to the unphosphorylated(one of three mammalian TGF-s) (Brown et al., 1999a;
Massague´, 1998). Betaglycan does not bind to Activins GS domain of type I receptors is thought to constrain
the basal activity by preventing ligand-independentor BMPs. Recently, however, betaglycan was shown to
bind to inhibin and to facilitate its access to Activin phosphorylation and activation of the receptor (Huse et
al., 1999). Once activated, the TGF- family receptorsreceptors, thus outpacing Activin and blocking its action
(Lewis et al., 2000). Cripto and other members of the are negatively regulated by the I-Smad, Smad7. Smad7
binds to the activated receptors in competition withCFC-EGF family, produced both as secreted factors and
as cell surface components, mediate the binding of R-Smads (Kavsak et al., 2000; Suzuki et al., 2002).
Smad7 interaction leads to the ubiquitination and degra-Nodal, Vg1, and GDF1 to Activin receptors (Cheng et
al., 2003; Rosa, 2002; Shen and Schier, 2000). In an dation of the receptors with the help of the E3 ubiquitin
ligases, the Smad ubiquitination regulatory factorsunusual case of dual function, connective tissue growth
factor (CTGF) has been shown to enhance TGF- bind- (Smurfs) (Ebisawa et al., 2001; Tajima et al., 2003). The
TGF- receptor-Smad7-Smurf complex is routed via ca-ing to its receptors and inhibit BMP4 binding to BMP
receptors (Abreu et al., 2002). veolin-rich membrane structures and internalized via ca-
veolin-positive vesicles toward the proteasome for deg-Genetic and biochemical evidence suggests that the
betaglycan-related protein endoglin facilitates binding radation (Di Guglielmo et al., 2003) (Figure 1). Below, we
discuss this process in the context of the role of Smad7of as yet unknown TGF- family members to the type I
receptor ALK1 in endothelial cells, and this role is critical in the termination of TGF- signaling.
for vascular homeostasis (Marchuk, 1998; Massague´ et
al., 2000). The ligand in question could be TGF- itself; Features of Smad Proteins
The first intracellular mediator of TGF- signaling, MAD,recent reports indicate that TGF- somehow activates
ALK1 in endothelial cells, creating a counterbalance be- was identified in Drosophila (Sekelsky et al., 1995),
quickly followed by the discovery of orthologs in wormtween ALK1 signaling via Smad1 and TR-I signaling
via Smad3 (Goumans et al., 2002) (Figure 2). and vertebrates, which were named “Smad” (Derynck
et al., 1996). Among the three classes of Smads, onlyThe protein BAMBI (BMP and Activin receptor mem-
brane bound inhibitor, also known as Nma) represents R-Smads are directly phosphorylated and activated by
the type I receptor kinases. Smad2 and Smad3 responda very different type of negative regulator of receptor
activation (Onichtchouk et al., 1999). BAMBI has struc- to signaling by the TGF- subfamily and Smads 1, 5,
and 8 primarily by the BMP subfamily (Figure 2).tural features of a decoy receptor, with an extracellular
domain and a short cytoplasmic region that share se- The R-Smad and Co-Smad proteins, with around 500
amino acids in length, contain two conserved structuralquence similarities with type I receptors. BAMBI com-
petes with the type I receptor for incorporation into domains, the N-terminal MH1 domain and the C-terminal
MH2 domain (Figure 6A). The R-Smads, but not the Co-ligand-induced receptor complexes, inhibiting receptor
activation. During Xenopus embryo development, Smads, contain a characteristic SXS motif at their C
termini. The MH1 (MAD-homology 1) domain of Smad4BAMBI expression is induced by BMP, creating a nega-
Cell
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Figure 6. Structure and Function of the Smad Protein
(A) Shown here is a phosphorylated R-Smad. The MH1 and MH2 domains are colored cyan and green, respectively. The DNA binding hairpin
is highlighted in orange. As predicted (Grishin, 2001), the MH1 domain also contains a tightly bound zinc atom as observed in a high-resolution
crystal structure (Chai et al., 2003). The L3 loop of the MH2 domain is colored purple. The C-terminal pSer-X-pSer motif is shown in ball-and-
stick representation.
(B) Phosphorylation of the SXS motif drives formation of homomeric as well as heteromeric complexes. Shown here is the homotrimeric
structure of the Smad2 MH2 domain with its C-terminal SXS motif homogeneously phosphorylated (Wu et al., 2001b). In the left panel, the
three Smad2 monomers are shown in blue, cyan, and green, with the L3 loop highlighted in pink. The right panel, with two Smad2 monomers
in surface representation and one in yellow coil, emphasizes the highly positively charged surface pocket next to the L3 loop that serves as
the binding site for the pSer-X-pSer motif. This basic surface pocket is conserved among all R-Smad as well as Smad4, suggesting a similar
interface between R-Smad and Smad4. The basic and acidic surfaces are colored blue and red, respectively.
and most R-Smads (except the most common splice tacting the nuclear pore complex for nucleocytoplasmic
shuttling. Importantly, the phosphorylation of the C-ter-form of Smad2) exhibits sequence-specific DNA binding
activity, may play a role in nuclear import, and negatively minal two serine residues in the SXS motif of the MH2
domain drives the activation of the R-Smad (Figure 6B).regulates the function of the MH2 domain. The N-ter-
minal domain of I-Smads displays weak sequence ho- Both the MH1 and MH2 domains interact with a large
number of proteins in the nucleus, effecting tran-mology to the MH1 domain of R-Smads but does not
bind to DNA. In contrast, the MH2 domain is highly scription.
Although the linker sequences between the MH1 andconversed among all Smad proteins and is responsible
for receptor interaction, formation of homomeric as well MH2 domains are divergent among Smads, these re-
gions contain multiple phosphorylation sites, whichas heteromeric Smad complexes, and directly con-
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allow specific crosstalks with other signaling pathways, Receptor-mediated phosphorylation of SARA bound
Smad2 occurs at the plasma membrane but is moreand a PY motif, which mediates specific interaction with
the Smurfs. Smurf1 and Smurf2 are HECT-domain-con- efficient in SARA-rich early endosomes to which the
activated receptor complex is internalized via clathrin-taining E3 ubiquitin ligases that target Smads as well
as Smad-associated TGF- receptors for degradation coated pits (Di Guglielmo et al., 2003; Hayes et al., 2002;
Lu et al., 2002) (Figure 1).by the 26S proteasome (Figure 1). Smad dephosphoryla-
tion also plays a role in the termination of the TGF- The activated TGF- receptor complex therefore un-
dergoes endocytosis via two distinct routes, for twosignal although the phosphatase(s) involved remains to
be identified. different purposes: it is internalized via coated vesicles
to early endosomes for signaling and via caveolae to
caveolin-positive vesicles for degradation (Di GuglielmoSmad Recognition by the Activated
et al., 2003). Another FYVE-containing protein, Hgs, wasReceptor Complex
found to cooperate with SARA on Smad signaling (Mi-How does the phosphorylated type I receptor exhibit a
rura et al., 2000). More recently, other adaptor proteins,significantly enhanced binding affinity for the R-Smad?
including Disabled-2 (Hocevar et al., 2001), Axin (Furu-One clue came from a structural comparison of the MH2
hashi et al., 2001), and the ELF -spectrin (Tang et al.,domains of Smad2 and Smad4, which revealed the pres-
2003) have been reported to facilitate TGF- signalingence of a much more positively charged surface patch
by linking Smad2/Smad3 to the receptor complex. How-on Smad2 than that on Smad4, located next to the L3
ever, the molecular mechanisms behind these interest-loop (Wu et al., 2000). Sequence analysis indicates that
ing observations remain unclear.this comparison holds true between all R-Smads and
the Co-Smad, Smad4. Thus this basic patch on R-Smad
was postulated to be the binding site for the phosphory- Mechanism of Smad Phosphorylation
lated GS region of the type I receptor (Wu et al., 2000) and Activation
(Figure 6). Indeed, mutation of one of the invariant resi- R-Smads are directly phosphorylated by the activated
dues, His331, in the basic patch of Smad2 leads to a type I receptors (Kretzschmar et al., 1997; Macias-Silva
reduction in its affinity for, and phosphorylation by, TRI et al., 1996). The structure of a Smad MH2 domain com-
(Huse et al., 2001). prises a central  sandwich, capped on one end by a
Although the predicted interaction between the phos- three-helix bundle and on the other end by a collection
phorylated GS region of the type I receptor and the basic of three surface loops and two auxiliary  helices (Shi,
patch of an R-Smad enhances binding affinity, it does 2001) (Figure 6A). In the crystal structures of the MH2
little to control the signaling specificity. The R-Smad domain from the unphosphorylated R-Smads, the
C-terminal sequence to be phosphorylated also contrib- C-terminal 10 residues, including the characteristic
utes little to the specificity of the receptor-Smad interac- SSXS motif at the extreme C terminus, are completely
tion. How, then, is a specific R-Smad chosen by the flexible and disordered (Qin et al., 2001; Shi, 2001; Wu
activated receptors? The answer lies in the L45 loop of et al., 2000). Several lines of evidence demonstrated
the receptor kinase domain, which is located immedi- that phosphorylation of an R-Smad takes place in the
ately adjacent to the GS region and specifies interac- C-terminal two serine residues within the flexible SSXS
tions with the R-Smads (Chen et al., 1998; Feng and motif (Abdollah et al., 1997; Souchelnytskyi et al., 1997).
Derynck, 1997) (Figure 5). The corresponding specificity Phosphorylation destabilizes Smad interaction with
determinant in the R-Smad primarily involves the L3 loop SARA, allowing dissociation of Smad from the complex
(Chen et al., 1998; Lo et al., 1998). Matching sets of and the subsequent exposure of a nuclear import region
Smad L3 loop and receptor L45 loop thus determine the on the Smad MH2 domain (Xu et al., 2000). In addition,
receptor-Smad choices delineated in Figure 2. However, R-Smad phosphorylation augments its affinity for
other sequence elements of R-Smads may also play a Smad4. The association of these two proteins nucleates
role in this interaction (Huse et al., 2001). A structure of the assembly of transcriptional regulation complexes.
an activated type I receptor bound to an R-Smad should Using glutamate to simulate the phosphorylated ser-
reveal the detailed mechanism for this recognition. ine residues, the MH2 domain of Smad1 and Smad3 was
shown to exhibit a greater propensity for the formation of
a homotrimer as well as a heteromeric Smad complexRegulation of Smad Access to the Receptors
The recognition of R-Smads by the receptors may be with Smad4 (Chacko et al., 2001). Mutational analysis
revealed that the residues in the L3 loop region of onefacilitated by auxiliary proteins. For example, Smad2
and Smad3 can be specifically immobilized near the cell Smad3 monomer are required for binding to the pseudo-
phosphorylated tail of an adjacent Smad3 monomersurface by the Smad anchor for receptor activation, or
SARA (Tsukazaki et al., 1998), through interactions be- (Chacko et al., 2001).
Using a protein-phosphopeptide ligation approach,tween a peptide sequence of SARA and an extended
hydrophobic surface area on Smad2/Smad3 (Wu et al., Smad2 and Smad3 proteins with the C-terminal two
serine residues of their SXS motif homogeneously phos-2000). SARA contains a phospholipid binding FYVE do-
main, which targets the molecule to the membrane of phorylated were generated (Wu et al., 2001b). Although
the unphosphorylated Smad proteins exhibit a weakearly endosomes (Tsukazaki et al., 1998). These interac-
tions allow more efficient recruitment of Smad2 or affinity for homotrimers, the phosphorylated Smad2 or
Smad3 forms an extremely stable homotrimer. Struc-Smad3 to the receptors for phosphorylation (Tsukazaki
et al., 1998). At steady state, the bulk of SARA and tural analysis of the phosphorylated Smad2-MH2 re-
veals the molecular basis for the formation of this stableSARA bound Smad2 are located in early endosomes.
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homotrimer (Wu et al., 2001b) (Figure 6B). The C-terminal The type I receptor interaction with R-Smad is also likely
mediated by the two contiguous pThr/Ser-X-pSer motifspSer-X-pSer motif of one Smad2 molecule is nestled
in a positively charged surface pocket of the adjacent of the phosphorylated GS domain and the basic surface
pocket of the MH2 domain (Figure 5). Therefore, themolecule through numerous specific hydrogen bonds.
In addition to these phosphorylation-specific contacts, pSer-X-pSer interaction with the MH2 basic surface
pocket represents the signature interaction of the recep-there is also a large protein-protein interface between
adjacent Smad2 molecules, similar to that observed in tor serine/threonine kinase signaling pathway.
the constitutively homotrimeric structure of Smad4 (Shi,
2001).
Importantly, the conformation of all structural ele- Mechanism of Smad Nucleocytoplasmic Shuttling
Receptor-mediated phosphorylation of the R-Smads in-ments in the MH2 domain of Smad2, except the N and
C termini, remains unchanged before and after phos- duces their accumulation in the nucleus. Since the acti-
vated type I receptors form a relatively stable complexphorylation (Wu et al., 2000; Wu et al., 2001b). This ex-
perimental observation is in contrast to a postulated with the R-Smads, how do these R-Smad proteins dis-
sociate from the receptor after phosphorylation? Theconformational change of Smad1 upon phosphorylation
(Qin et al., 2001), derived from comparing the structure answer resides, at least in part, in the ability of the
phosphorylated SXS motif to compete with the GS re-of an unphosphorylated Smad1 (Qin et al., 2001) with
that of an unphosphorylated Smad2 (Wu et al., 2000). gion of the receptor for binding to the basic surface
pocket located next to the L3 loop of the R-Smads (WuIn addition, the observed conformational change at the
N terminus of Smad2-MH2, involving a large movement et al., 2001b) (Figure 5). This model predicts that loss of
phosphorylation on the SXS motif may lead to prolongedof the B1 strand, provides a plausible explanation to the
decreased binding affinity for SARA (Wu et al., 2001b), as association between an R-Smad and the receptor ki-
nases, a prediction well supported by the evidencethis  strand is also required for interaction with SARA
(Wu et al., 2000). (Abdollah et al., 1997; Lo et al., 1998; Souchelnytskyi et
al., 1997). Additionally, phosphorylation of Smad2 de-
creases its affinity for the binding site of SARA (Xu etpSer-X-pSer as the Defining Motif
al., 2000).of the TGF- Pathway
In the basal state, R-Smads are predominantly local-The phosphorylated Smad2 structure not only explains
ized in the cytoplasm, whereas the I-Smads tend to bethe molecular mechanism for the formation of a homotri-
nuclear. Smad4 is distributed in both the cytoplasm andmer for R-Smad, but also reveals significant insights
the nucleus. After receptor activation, the phosphory-into the mechanism of R-Smad binding to Smad4. In
lated R-Smads are translocated into the nucleus. Thethe structure of the phosphorylated Smad2, the pSer-
Smad MH1 domain contains a conserved lysine-richX-pSer motif is primarily coordinated by four important
helix—the helix H2—located next to the DNA bindingresidues in the positively charged surface pocket; all
motif -hairpin (Figure 6A) (Chai et al., 2003; Shi et al.,four residue are preserved in Smad4, strongly indicating
1998). The solvent-exposed C-terminal portion of thisthat a similar surface pocket on Smad4 serves as the
helix (KKLKK), invariant among all R-Smads, has beenbinding site for the pSer-X-pSer motif of the R-Smads
suggested to act as a nuclear localization signal (NLS)in the heteromeric Smad complex (Wu et al., 2001b). This
for Smad1 and Smad3 (Xiao et al., 2000a, 2001). Thisconclusion is supported by biochemical and mutational
activity has been shown to depend on Smad phosphory-analyses (Chacko et al., 2001; Wu et al., 2001b).
lation (Kurisaki et al., 2001; Xiao et al., 2000b). This pro-The stoichiometry of the heteromeric Smad com-
tein interaction is different from the interaction of theplexes has been subjected to much debate (Chacko et
classical importin pathway. In that pathway, importin al., 2001; Kawabata et al., 1998; Shi, 2001). Using iso-
binds to importin , which recognizes as an NLS anlated MH2 domains, strong evidence was presented ei-
extended lysine-rich sequence in the cargo moleculether to favor a heterotrimer model (Chacko et al., 2001;
(Gorlich and Kutay, 1999; Mattaj and Englmeier, 1998).Qin et al., 2001) or to support a heterodimer model be-
In the Smad MH1 nuclear import studies, however, thetween Smad4 and the R-Smad (Wu et al., 2001a; Wu et
basic sequence in question is part of an -helix (Chaial., 2001b). Investigation of the Smad stoichiometry in
et al., 2003; Shi et al., 1998), and it binds to importin ,cells suggests a complex situation (Jayaraman and Mas-
but not importin  (Kurisaki et al., 2001; Xiao et al.,sague´, 2000). More recently, it was suggested that, de-
2000b).pending on the gene promoter context, both a hetero-
An alternative mechanism for the nuclear import andtrimer and a heterodimer are possible (Inman and Hill,
export of Smad2 (and Smad3) has been elucidated2002). Indeed, this issue can only be addressed in a
based on the observation that the MH2 domain bindsbiologically relevant manner by investigating the active
directly to components of the nuclear pore complex,heteromeric Smad complexes in the nucleus.
the nucleoporins CAN/Nup214 and Nup153 (Xu et al.,Regardless of the stoichiometry for the heteromeric
2002). Binding is mediated by the FG (Phe-Gly) repeatSmad complex, it has become clear that the interface
region of these nucleoporins. This allows Smad importbetween the C-terminal pSer-X-pSer motif of the R-Smad
into the nucleus in the absence of added importins andand the basic surface pocket of the Smad4 MH2 domain
export independently of the general export factor Crm-1play a dominant role in the formation of a heteromeric
(Xu et al., 2002). By directly contacting the nuclear porecomplex (Wu et al., 2001b). This conclusion is supported
complex, Smad2 undergoes constant shuttling, provid-by all published observations as well as the skewed
distribution of the tumor-derived missense mutations. ing a dynamic pool that is competitively drawn by cyto-
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TGF- stimulation of epithelial cells, receptors remain
active for a few hours, and this activity is required to
maintain the active Smads in the nucleus for TGF-
-regulated transcription (Inman et al., 2002). Continu-
ous shuttling of R-Smad with repeated cycles of recep-
tor-mediated phosphorylation, and dephosphorylation,
permits constant sensing on the activation status of the
TGF- receptor and ensures an efficient termination of
signaling upon receptor inactivation.
Smad4 accumulates in the nucleus by association
with activated R-Smads (Hoodless et al., 1999; Liu et
al., 1997; Watanabe et al., 2000). However, Smad4 also
undergoes continuous nucleocytoplasmic shuttling on
its own, independently of TGF- signaling (Pierreux et
al., 2000; Watanabe et al., 2000). The nuclear import
signal in Smad4 includes not only just lysine residues
in the H2 helix of the MH1 domain, but also a basic
residue Arg81 in thehairpin (Xiao et al., 2003). A nuclear
export signal is present in the linker region of Smad4 and
may be masked through the formation of a heteromeric
complex with R-Smads (Inman et al., 2002; Watanabe
et al., 2000; Xiao et al., 2001). An alternatively spliced
form of Smad4 in mammals (Pierreux et al., 2000) and
a separate gene product—Smad4, also known as
Smad10—in Xenopus (Watanabe et al., 2000) lack the
NES and are constitutively nuclear.
Negative Regulation of Smad Nuclear Accumulation
Ras and TGF- signals act cooperatively as well as an-
tagonistically during development and in oncogenesis.
Although TGF- can override the proliferative effects
of EGF and other Ras-activating mitogens in normal
epithelial cells, oncogenic activation of Ras suppresses
the cytostatic effects of TGF-. As Ras has diverse ef-
fectors and targets in the cell, its interplay with TGF-
signaling is likely to occur at multiple levels, many ofFigure 7. Nucleocytoplasmic Shuttling of the Smad Proteins
which involve indirect molecular interaction. However,(A) A schematic diagram showing the nucleocytoplasmic shuttling
it has been shown that Ras-mediated activations of Erkof Smad2, with proteins that compete for Smad2 binding shown in
red. MAP kinases results in the phosphorylation of Smads
(B) A hydrophobic corridor on R-Smads is the common interaction 1, 2, and 3 at MAP kinase sites in the linker sequence
site for many Smad cofactors. The hydrophobic surface patch of between the MH1 and MH2 domains, and this attenuates
Smad2 (Wu et al., 2000) is colored blue. The bound SARA fragment agonist-induced nuclear accumulation of these Smads
is shown in pink.
and alters Smad-dependent transcription (Kretzschmar
et al., 1999, 1997). Oncogenic Ras also appeared to
induce degradation of Smad4 (Saha et al., 2001).
plasmic and nuclear signal transduction partners (Fig- The effect of these MAP kinase phosphorylation sites
ures 1 and 7A). on Smad nuclear accumulation is subtle in some cell
The nucleoporin-interacting site in Smad2 overlaps types and conditions but profound in others. For exam-
the SARA binding site in the MH2 domain as defined by ple, in Xenopus frog embryos, Activin signaling leads to
the crystal structure of a Smad2-SARA complex (Wu Smad2 nuclear accumulation and, with that, induction
et al., 2000) (Figure 7B). This site, referred to as the of mesodermal marker genes for many hours; this ends
“hydrophobic corridor,” also serves as the common abruptly with a nuclear exclusion of Smad2 dependent
binding site for SARA and nuclear transcription factors on the MAP kinase phosphorylation sites in the linker
as they share a conserved Smad interacting motif or region (Grimm and Gurdon, 2002). The mechanism medi-
SIM (Randall et al., 2002). SARA in the cytoplasm and ating Smad nuclear exclusion via MAP kinase phosphor-
Smad partners in the nucleus compete with CAN/ ylation is not known. It could involve direct effects on
Nup214 and Nup153 for binding to the hydrophobic cor- the Smad nuclear import or export processes or, alter-
ridor (Xu et al., 2002) (Figure 7B). Receptor-mediated natively, effects on Smad interaction with functional
phosphorylation of Smad2 decreases its binding affinity partner proteins that secondarily affect the subcellular
for SARA, but not for CAN/Nup214 or Nup153 (Tsukazaki distribution of Smads. On the other hand, the JNK path-
et al., 1998; Xu et al., 2000, 2002). way has also been shown to have positive effects on
Continuous nucleocytoplasmic shuttling of the Smad Smad function, although the phosphorylation sites in-
proteins appears to be a key event in TGF- signaling volved in this process remain under investigation (Brown
et al., 1999b).(Inman et al., 2002; Xu et al., 2002) (Figure 7A). Following
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tively spliced variant of Smad2 lacking this insertion
(Yagi et al., 1999).
The relatively low specificity of DNA binding by Smads
has created difficulty in the identification of biologically
relevant Smad-responsive DNA elements. For example,
while Smad4, Smad3, and Smad1 bind specifically to
SBE (Johnson et al., 1999; Shi et al., 1998; Zawel et al.,
1998), they have also been reported to bind to G/C-rich
sequences (Ishida et al., 2000; Kim et al., 1997; Labbe
et al., 1998). This challenge is further confounded by the
highly positively charged helix H2 of the MH1 domain,
which resides next to the DNA binding -hairpin in the
crystal structure (Shi, 2001) (Figure 8B). It has been doc-
umented that clusters of lysine residues generally prefer
G/C-rich sequences (Choo and Klug, 1997). Can the
Smad MH1 domain interact with two distinct sets of
DNA sequences using two different sequence motifs?
If the answer were positive, this would represent the
first such case.
Mechanism of Target Gene Selection
Figure 8. Specific DNA Recognition by the Smad Proteins Cell stimulation with TGF- leads immediately to posi-
(A) Structure of a Smad3 MH1 domain bound to SBE (Chai et al., tive and negative changes in the expression of several
2003; Shi et al., 1998). The DNA binding -hairpin is highlighted hundred genes (Kang et al., 2003). Both activation and
in yellow. The two DNA strands are colored blue and magenta, repression of gene expression use the same set of acti-
respectively.
vated Smad proteins. Further compounding this com-(B) Closeup views of the highly positively charged helix H2. The left
plexity, many of these gene responses depend on thepanel shows the ribbon diagram of Smad3 MH1 structure, with
cell type and other conditions affecting the cell at theseven Lys residues shown in red. The positions of the H2 helix
and the -hairpin are indicated. The right panel shows the surface time of TGF- stimulation.
electrostatic potential of Smad3 MH1 domain. A general hypothesis for how cells read TGF- signals
posits that Smad access to target genes and the recruit-
ment of transcriptional coactivators or corepressors toSimilar to the effect of Erk, calcium-calmodulin-
such genes depend on cell-type specific partner pro-dependent protein kinase II, acting downstream of other
teins (Massague´, 2000). This hypothesis appears to begrowth factor receptors, inhibits TGF- signaling
true even for Smad7, whose promoter contains two cop-through phosphorylation of Smad2 at several residues
ies of SBE and whose expression is activated by both
in the linker region (Wicks et al., 2000). Although these
TGF- signaling and BMP signaling largely in a cell type-
residues are different from the MAP kinase sites, their
independent manner. Binding to this promoter se-
phosphorylation also inhibited Smad2 nuclear accumu- quence involves Smad3, Smad4, and at least one addi-
lation (Wicks et al., 2000). tional component (Denissova et al., 2000; Inman and
Hill, 2002).
Basis for DNA Recognition by Smad Proteins Most Smad-responsive enhancers, however, contain
Smad4 and all R-Smads except Smad2 bind to DNA in only one copy of the SBE. Because of the relatively low
a sequence-specific manner. The minimal Smad binding specificity of DNA binding by individual Smad proteins,
element (SBE), initially identified as the optimal DNA Smads must cooperate among each other and with
binding sequence for Smad3 and Smad4, contains only other DNA binding proteins to elicit specific transcrip-
four base pairs, 5-AGAC-3 (Dennler et al., 1998; Ying- tional responses (Figure 9A). Some of these factors may
ling et al., 1997; Zawel et al., 1998), although most natu- be ubiquitous and mediate the same response in all cell
rally occurring DNA sequences contains an extra base types (Figure 9A, gene 1). Others Smad partners or their
C at the 5 end. The crystal structure of the Smad3 MH1 activators may be cell-type restricted, giving rise to cell-
domain bound to SBE revealed that a highly conserved type dependent gene responses (Figure 9A, genes 2–4).
 hairpin makes specific contacts to three bases of the Remarkably, members from many different families of
SBE (Chai et al., 2003; Shi et al., 1998) (Figure 8A). The DNA binding proteins—forkhead (e.g., Fast1), homeo-
conserved nature of the DNA binding  hairpin as well as box (e.g., Mixer), E-box, Jun/Fos, Runx, CREBP, and
its surrounding sequence elements among all R-Smads E2F—have been shown to function as Smad partners
strongly suggests that other R-Smads should specifi- in this fashion. Since this topic has been extensively
cally bind to SBE as well (Shi et al., 1998). Compared reviewed recently (Attisano and Wrana, 2000; Massague´
to other Smads, the most common splice form of Smad2 and Wotton, 2000; ten Dijke et al., 2000), we will restrict
contains a unique 30 residue insertion between the DNA our discussion to recent progress and focus on the
binding  hairpin and the helix H2; this sequence varia- shared mechanisms.
tion resulted in the poor DNA binding ability of Smad2,
presumably due to disruption of the conformation of the Mechanisms of Transcriptional Control
DNA binding hairpin (Shi et al., 1998). In support of this The MH2 domain of the Smad proteins exhibits trans-
activation function as a heterologous fusion with GAL4explanation, DNA binding was restored in the alterna-
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E2F4/5 and DP1, and the corepressor p107 preexists in
the cytoplasm. In response to TGF-, this complex
moves into the nucleus and associates with Smad4,
recognizing a composite Smad-E2F site on c-myc for
repression (Figure 9B). Previously known as the ultimate
recipients of CDK regulatory signals, E2F4/5 and p107
act here as transducers of TGF- receptor signals
upstream of CDK. Since Myc directly represses the
expression of p15Ink4b through association with the
transcription factor Miz-1 (Seoane et al., 2001; Staller
et al., 2001), the Smad-E2F-p107-mediated repression
of c-myc also relieves Myc-mediated repression of
p15Ink4b (Figure 9B). Thus, the Smad proteins can medi-
ate transcriptional activation or repression depending
on their associated partners.
Regulation of Smad-Dependent Transcription
Among the negative regulators of Smad transcriptional
function, c-Ski and SnoN are two highly conserved
members of the Ski family of protooncoproteins. Ski or
SnoN antagonize TGF- signaling through direct inter-
actions with Smad4 and the R-Smads (Liu et al., 2001;
Wang et al., 2000). The mechanism of Ski-mediated re-
pression of TGF- signaling was primarily attributed to
transcriptional modulation, through recruitment of the
nuclear transcriptional corepressor (N-CoR) and histone
deacetylase (HDAC) as well as interference of Smad-
mediated binding to the transcriptional coactivator,
p300/CBP (Liu et al., 2001). One additional mechanism
Figure 9. Transcriptional regulation by the Smad proteins was provided by the recent structure of the Smad4 bind-
(A) Context-dependent transcriptional responses by the Smad com- ing domain of c-Ski in complex with the MH2 domain
plexes. The ubiquitous factors may give rise to a uniform response of Smad4, which reveals an overlap between the Ski
in different cell types. The cell-specific factors dictate differential binding and R-Smad binding surfaces on Smad4 (Wu
responses in different cell types for the same Smad proteins.
et al., 2002). Indeed, Ski competes with R-Smads for(B) A schematic diagram of the transcriptional regulation on the Myc
interaction with Smad4 and disrupts the formation ofand p15Ink4b genes by the Smad proteins in epithelial cells.
a functional complex between Smad4 and R-Smads.
Because Ski contains separate sequence elements for
interaction with Smad4 and R-Smads, both Smad4 andDNA binding domain, suggesting that Smads may di-
rectly associate with the basal transcriptional machin- R-Smad may remain attached to Ski after disruption of
the functional complex (Luo et al., 1999; Stroschein etery. Indeed, the MH2 domain of both R-Smads and
Smad4 interacts with the transcriptional coactivators al., 1999; Wu et al., 2002).
SnoN-mediated negative regulation on the Smad pro-CBP, p300, ARC105, and Smif (Bai et al., 2002; Derynck
et al., 1998; Kato et al., 2002; Massague´ and Wotton, teins is removed during TGF- signaling by at least two
distinct ways. In the presence of TGF- signaling,2000). How, then, does TGF- signaling via Smad pro-
teins lead to activation or repression in the same cell at Smad2 interacts with both SnoN and Smurf2, allowing
the HECT domain of Smurf2 to target SnoN for ubiquitin-the same time, depending on the target gene? Analysis
of the cell cycle arrest response to TGF- in epithelial mediated degradation by the proteasome (Bonni et al.,
2001). Smad2 and Smad3 can also recruit the E3 ubiqui-cells, which has been intensely pursued because of its
relevance to cancer, has provided insights into this tin ligase anaphase promoting complex (APC), resulting
in the ubiquitination and degradation of Smad boundquestion.
Two of the most important cytostatic gene responses SnoN (Stroschein et al., 2001; Wan et al., 2001).
Smads can also bind to transcriptional corepressorto TGF- in epithelial cells are activation of p15Ink4b,
which encodes a cyclin-dependent kinase (CDK) in- TGIF (Wotton et al., 1999a), which in turn recruits HDAC
and other repressors via the adaptor protein Sin3 andhibitor, and repression of c-myc, which encodes a
potent transcriptional activator of genes required for CtBP to repress transcription (Wotton et al., 2001,
1999a, 1999b). Like Ski and SnoN, TGIF is thought togrowth and proliferation (Massague´ et al., 2000). A TGF-
-activated Smad complex that may also include Sp1 act as an inhibitor of TGF--dependent gene activation
rather than as a mediator of TGF--dependent geneand other as yet unidentified factors recognizes the
p15Ink4b promoter for activation (Figure 9B) (Feng et repression.
TGIF additionally provides a point for negative regula-al., 2000; Seoane et al., 2001). How in the same cells
the activated Smad proteins mediate repression of tion of TGF- signaling by the Ras-MEK-MAPK pathway.
Ras-activating growth factors including EGF and HGF,c-myc was recently characterized (Chen et al., 2002).
A complex containing Smad3, the transcription factors as well as Ras-activating oncogenic mutations, signal-
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Smurf1 and Smurf2 form a stable complex with Smad7.
Using their N-terminal C2 domain, Smurf1 and Smurf2
target the Smurf-Smad7 complex to the plasma mem-
brane, where Smad7 directly binds to the activated type
I TGF- receptor and inhibits phosphorylation of the
R-Smads (Kavsak et al., 2000; Suzuki et al., 2002). In
the membrane complex, Smurf1 also directly mediates
the ubiquitination and turnover of the receptors (Ebi-
sawa et al., 2001; Tajima et al., 2003). Smad7 itself under-
goes ubiquitination and degradation in this process.
However, this negative feedback loop is perpetuated
by the ability of TGF- (and BMPs) to transcriptionally
activate Smad7, thus ensuring a steady supply of the
protein as it undergoes degradation (Figure 10).
In the nucleus, Smad7 is associated with the nuclear
acetyl transferase p300, which acetylates lysine resi-
dues 64 and 70 in Smad7, protecting it against Smurf-
mediated ubiquitination of the same residues (Gronroos
et al., 2002). Smad7 acetylation is lost as the protein
leaves the nucleus in response to TGF- stimulation and
separates from p300. Although R- and Co-Smads also
associate with p300 and the related acetyl transferase
CBP in the context of assembling transcriptional com-
plexes, no evidence has been found that R- or Co-
Smads undergo acetylation.Figure 10. A Schematic Diagram on the Function of the Inhibitory
Smad6 acts in a different manner. It competes withSmads (I-Smads)
the activated Smad1 for binding to Smad4, serving asTranscriptionally activated by TGF- signaling, Smad7 promotes the
ubiquitination and degradation of the receptors via Smurf. Smad6 an inhibitor of BMP signaling (Hata et al., 1998). Smad6
competes with Smad1 for binding to the Co-Smad, Smad4. can be sequestered by the protein AMSH upon nuclear
export in response to BMP (Itoh et al., 2001). The WD40
domain-containing protein STRAP is thought to facilitate
ing via MEK, cause the phosphorylation of TGIF at two Smad7 recruitment to the activated TGF- receptor
Erk MAP kinase sites. This leads to stabilization of the complex (Datta and Moses, 2000). Beyond this, the ele-
TGIF protein, favoring the formation of Smad2-TGIF co- ments responsible for the constitutive nuclear localiza-
repressor complexes in response to TGF- (Lo et al., tion of I-Smads or their signaling-dependent export re-
2001). Thus, the Smad and Ras pathways can intersect main unknown.
at both the Smad nuclear translocation level and the These observations underscore the complex mecha-
transcriptional level in the nucleus. nisms controlling TGF- signaling and suggest the
involvement of additional factors that may regulate
the stability of Smad proteins at both the basal and theEnding Smad Signaling
activated states. Furthermore, Smad7 is used not onlyDephosphorylation by as yet unidentified phosphatases
to establish a negative feedback loop in TGF- signaling,(Randall et al., 2002) as well as ubiquitination and protea-
but also to negatively regulate this pathway by antago-some-mediated degradation of the activated R-Smads
nistic signals. Thus, the proinflammatory cytokines inter-are two mechanisms for the termination of Smad signal-
feron- and tumor necrosis factor-, signaling via Stat1ing (Figure 1). Smurf1 targets Smad1 and Smad5 for
and NF-B, respectively, activate Smad7 expressiondestruction in the cytoplasm of unstimulated cells (Zhu
with an attendant inhibition of TGF- signaling (Bitzeret al., 1999). This function may be important for the
et al., 2000; Ulloa et al., 1999).maintenance of the basal state in the unstimulated cells.
However, activated Smad2 is ubiquitinated in the nu-
cleus and undergoes proteasome-mediated degrada- Perspectives
In essence, the TGF- signal transduction pathway astion (Lo and Massague´, 1999); this process may involve
Smurf2, which has extensive sequence similarity to we know it involves a ligand-activated receptor complex
that promotes the formation of Smad transcriptionalSmurf1 (Lin et al., 2000; Zhang et al., 2001). Ubiquitina-
tion of activated Smad3 appears to be mediated by complexes. The simplicity of this pathway is in sharp
contrast with the great diversity of cell-specific genea different E3, the SCF/Roc1 complex (Fukuchi et al.,
2001). responses that it triggers and its dependence on the
context. In fact, by focusing here on the central compo-Smurf1 and 2 also mediate ubiquitination of activated
TGF- receptors, leading to their degradation in the pro- nents of the TGF- pathway, we have largely side-
stepped two of its main defining features: the cell-typeteasome (Ebisawa et al., 2001; Tajima et al., 2003). The
inhibitory Smad, Smad7, plays an important role in this dependence of its actions and its many links with other
signaling pathways (reviewed in Massague´ et al., 2000).process. Smad7 resides in the nucleus in the basal state
and moves to the plasma membrane upon TGF- or Much work is needed for the delineation of cell-type
specific gene responses that mediate the action of theBMP stimulation (Itoh et al., 1998) (Figure 10). Both
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